ATLANTA (AP) — An official has been put on leave and others reassigned following a report of a cancer patient bitten more than 100 times by ants at a U.S. Department of Veterans Affairs living...
U.S. regulators Friday approved the first targeted drug for certain patients with an aggressive form of leukemia.
The Food and Drug Administration approved the drug for adults with acute myeloid leukemia, or AML, who have a genetic mutation called FLT3. Also OK'd was a test to identify those patients. The drug, Rydapt, known chemically as midostaurin, is used along with chemotherapy.
- Business WireNEO Connect Welcomes Stone Asset Management PTFSeptember 10, 2019 GMT
- BusinessWireReliant Bank Names Richard Stone as Market President for Rutherford CountyAugust 7, 2018 GMT